Research progress of biomarker COMP in osteoarthritis.
- Author:
Tai-Hang ZHU
1
;
Chun-Yuan CAI
;
Lei ZHANG
Author Information
1. Department of Orthopaedics and Trauma Surgery, the Third Affiliated Hospital of Wenzhou Medical College, Zhejiang, China.
- Publication Type:Journal Article
- MeSH:
Biomarkers;
blood;
Cartilage Oligomeric Matrix Protein;
Extracellular Matrix Proteins;
blood;
chemistry;
metabolism;
Glycoproteins;
blood;
chemistry;
metabolism;
Humans;
Matrilin Proteins;
Osteoarthritis;
blood;
diagnosis;
Prognosis
- From:
China Journal of Orthopaedics and Traumatology
2010;23(12):959-961
- CountryChina
- Language:Chinese
-
Abstract:
Cartilage oligomeric matrix protein (COMP) is a potential biomarker for joint destruction associated with osteoarthritis, which is first and best investigated biomarkers to reflect osteoarthritis occurs, progress and the prognosis. In this article, multiple uses and related reports of COMP are summarized briefly to promote further investigation of COMP.
